NO954495L - Germ-line mutations in the MTS gene and method for detecting the predisposition to cancer by the MTS gene - Google Patents

Germ-line mutations in the MTS gene and method for detecting the predisposition to cancer by the MTS gene

Info

Publication number
NO954495L
NO954495L NO954495A NO954495A NO954495L NO 954495 L NO954495 L NO 954495L NO 954495 A NO954495 A NO 954495A NO 954495 A NO954495 A NO 954495A NO 954495 L NO954495 L NO 954495L
Authority
NO
Norway
Prior art keywords
mts gene
predisposition
germ
cancer
detecting
Prior art date
Application number
NO954495A
Other languages
Norwegian (no)
Other versions
NO954495D0 (en
Inventor
Mark H Skolnick
Lisa A Cannon-Albright
Alexander Kamb
Original Assignee
Univ Utah Res Found
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27539687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO954495(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Utah Res Found, Myriad Genetics Inc filed Critical Univ Utah Res Found
Publication of NO954495D0 publication Critical patent/NO954495D0/en
Publication of NO954495L publication Critical patent/NO954495L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO954495A 1994-03-18 1995-11-08 Germ-line mutations in the MTS gene and method for detecting the predisposition to cancer by the MTS gene NO954495L (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21508794A 1994-03-18 1994-03-18
US21508694A 1994-03-18 1994-03-18
US21458294A 1994-03-18 1994-03-18
US22736994A 1994-04-14 1994-04-14
US25193894A 1994-06-01 1994-06-01
PCT/US1995/003537 WO1995025813A1 (en) 1994-03-18 1995-03-17 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene

Publications (2)

Publication Number Publication Date
NO954495D0 NO954495D0 (en) 1995-11-08
NO954495L true NO954495L (en) 1996-01-17

Family

ID=27539687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954495A NO954495L (en) 1994-03-18 1995-11-08 Germ-line mutations in the MTS gene and method for detecting the predisposition to cancer by the MTS gene

Country Status (11)

Country Link
US (9) US5801236A (en)
EP (1) EP0702730A4 (en)
JP (1) JPH08510391A (en)
CN (1) CN1128049A (en)
AU (1) AU685627B2 (en)
CA (1) CA2162150C (en)
FI (1) FI955416A (en)
NO (1) NO954495L (en)
NZ (1) NZ284612A (en)
RU (1) RU2161309C2 (en)
WO (1) WO1995025813A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962316A (en) * 1992-10-16 1999-10-05 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US7691632B2 (en) * 1993-11-18 2010-04-06 Cold Spring Harbor Laboratory Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression
WO1995019369A1 (en) 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US6060301A (en) * 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
EP0702730A4 (en) * 1994-03-18 1997-05-07 Univ Utah Res Found Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
US6689864B1 (en) 1994-04-14 2004-02-10 The Regents Of The University Of California Cyclin dependent kinase 4 inhibitor
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
HUP9901908A3 (en) 1995-07-17 2000-02-28 Univ Texas P16 expression constructs and their application in cancer therapy
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
GB9519275D0 (en) * 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
US5723313A (en) 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US6586203B1 (en) 1995-09-27 2003-07-01 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
CN1181422A (en) * 1996-10-31 1998-05-13 上海市肿瘤研究所 Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor
ATE332896T1 (en) 1997-10-27 2006-08-15 Agouron Pharma 4-AMINOTHIAZOLE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
US6897018B1 (en) * 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
WO1999045021A1 (en) * 1998-03-03 1999-09-10 Affymetrix, Inc. Cell cycle regulated genes
US6183958B1 (en) * 1998-05-06 2001-02-06 Variagenics, Inc. Probes for variance detection
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
US6576420B1 (en) * 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
DE19829473C2 (en) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Procedure for early diagnosis of carcinomas
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
KR20000038917A (en) * 1998-12-10 2000-07-05 성재갑 Method for manufacture of cdk6/p16 complex using insect cell
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6174681B1 (en) * 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
AU5446700A (en) * 1999-05-28 2000-12-18 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
US6723548B2 (en) 2000-05-23 2004-04-20 Board Of Regents, The University Of Texas System DNA repair polypeptides and methods of use
ES2291246T3 (en) * 2000-06-27 2008-03-01 Von Recklinghausen Gesellschaft E.V. PROCEDURE FOR PURCHASING DATA FOR THE PRESINTOMATIC OR PRENATAL DIAGNOSIS OF NEUROPHRIBROMATOSIS OF TYPE 1.
US7906492B2 (en) * 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
AU2003228517B2 (en) * 2002-04-16 2007-06-21 Dana-Farber Cancer Institute, Inc. Cancer models
EP1507148B1 (en) * 2003-08-25 2005-02-23 MTM Laboratories AG Method for detecting carcinomas in a solubilized cervical body sample
US6909444B2 (en) * 2002-09-09 2005-06-21 Dai Nippon Printing Co., Ltd. Transfer ribbon, image expressing medium and method for production of them
US20070270504A1 (en) * 2003-06-20 2007-11-22 Avalon Pharmaceuticals, Inc. Identification of Therapeutic Agents Using Genetic Fingerprinting
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
CN101507822B (en) * 2003-11-24 2012-06-06 坎吉有限公司 Reduction of dermal scarring
EP1799230B1 (en) 2004-08-27 2012-11-21 Cyclacel Limited Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
RU2511408C2 (en) * 2007-09-17 2014-04-10 Конинклейке Филипс Электроникс Н.В. Method for analysing disorders related to ovarian carcinoma
WO2009077642A1 (en) * 2007-12-19 2009-06-25 University Of Helsinki Screening method
WO2010068850A1 (en) * 2008-12-12 2010-06-17 Georgetown University Methods of diagnosing and treating cancer
US8715937B2 (en) 2010-11-15 2014-05-06 Exact Sciences Corporation Mutation detection assay
RU2484096C1 (en) * 2012-02-08 2013-06-10 Общество с ограниченной ответственностью "Технофарма" SINGLE-DOMAIN ANTIBODY aMts1 SPECIFICALLY BINDING PROTEIN S100A4/Mts1, METHOD FOR PREPARING AND USING FOR DETECTION OF THIS PROTEIN
CN103127528B (en) * 2012-09-14 2016-04-20 苏州大学 Mankind DCX gene is preparing the application in radiotherapy of glioma sensitizer
CN106701920A (en) * 2016-11-25 2017-05-24 苏州首度基因科技有限责任公司 Kit for predicting colorectal cancer liver metastases and use method
RU2694231C1 (en) * 2018-01-09 2019-07-10 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Башкирский Государственный Педагогический Университет Им. М. Акмуллы" Method of predisposition to oncopathology determination

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801038A (en) * 1984-05-29 1998-09-01 Genencor International Inc. Modified subtilisins having amino acid alterations
CA2086829A1 (en) * 1990-07-09 1992-01-10 Sayeeda Zain Diagnosis of metastatic cancer by the mts-1 gene
US5889169A (en) * 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
DE69333043T2 (en) * 1992-10-16 2004-05-06 Cold Spring Harbor Laboratory TRANSFERRATION OF THE CYCLIN COMPLEX AND ITS RELATED APPLICATIONS
US5962316A (en) * 1992-10-16 1999-10-05 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US6211334B1 (en) * 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
US6043030A (en) * 1992-12-17 2000-03-28 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
US5919997A (en) * 1993-11-18 1999-07-06 Cold Spring Habor Labortary Transgenic mice having modified cell-cycle regulation
EP0702730A4 (en) * 1994-03-18 1997-05-07 Univ Utah Res Found Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof

Also Published As

Publication number Publication date
CA2162150C (en) 2010-03-30
CA2162150A1 (en) 1995-09-28
AU685627B2 (en) 1998-01-22
US5994095A (en) 1999-11-30
US6090578A (en) 2000-07-18
AU2378995A (en) 1995-10-09
JPH08510391A (en) 1996-11-05
EP0702730A4 (en) 1997-05-07
EP0702730A1 (en) 1996-03-27
FI955416A0 (en) 1995-11-10
FI955416A (en) 1996-01-09
US5624819A (en) 1997-04-29
WO1995025813A1 (en) 1995-09-28
US6180776B1 (en) 2001-01-30
NO954495D0 (en) 1995-11-08
US6037462A (en) 2000-03-14
NZ284612A (en) 1997-09-22
US6218146B1 (en) 2001-04-17
US6140473A (en) 2000-10-31
US5739027A (en) 1998-04-14
US5801236A (en) 1998-09-01
RU2161309C2 (en) 2000-12-27
CN1128049A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
NO954495D0 (en) Germ-line mutations in the MTS gene and method for detecting the predisposition to cancer by the MTS gene
NO970320L (en) System for use in well-completion
HUP9901856A3 (en) Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
GB9110500D0 (en) Slab electrophoresis system with improved sample wells and cooling mechanism
FI951801A0 (en) CTLA4 molecules and IL4 binding molecules and their use
KR970004976A (en) Sampler for the reading of plasma
DE69833807D1 (en) Supported bisphosphorus ligands; their use in hydrocayngation processes
FI102476B1 (en) New transition metal complexes and method for their preparation
ZA9811783B (en) On-line measuring system and method
NO972003D0 (en) Method for determining self-diffusion properties
DE69515643T2 (en) PROBE SAMPLE
EP1060263A4 (en) Method and compositions for detecting luciferase in biological samples
FI955415A (en) MTS gene, its mutations and methods for detecting cancer using MTS gene sequences
GB9511752D0 (en) Protein biosensor and method for protein measurement
DE59707845D1 (en) cryostatic
DE69514851T2 (en) Interatomic measurement method
FI940225A (en) Method for determining the metal in the sample
AU8480298A (en) Apparatus and process for measuring absorbance in fluid samples
GB2301443B (en) Apparatus for measuring angles for mitres and bevels
FI981428A0 (en) Reference substance for use in the analysis of levosimendan batches
DE19581529T1 (en) On-line barcode verification system
ATE196800T1 (en) MEASURING SYSTEM AND METHOD
FI954344A (en) Method for determining metal in the sample
EP0598460A3 (en) Method for analysing substances and measuring cell for carrying out the method.
FI982669A0 (en) System and method for optimizing the analysis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application